Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China, India Seen As Trend-Setters In Emerging Market Pharma Growth

This article was originally published in PharmAsia News

Executive Summary

China is expected to be among the leaders of a growing trend of growth in the global pharmaceutical industry being led by the emerging markets. That realization has attracted the attention of multinational and domestic drug makers that seek to benefit from the new markets that include China and India as well as Mexico and Turkey. IMS China Health Market Research Consulting said in a report that China's pharmaceutical market should continue growing at the rate of 20 percent this year, although down from the 26 percent registered in 2008, thanks in part to new health care reforms. China's health minister said changes in the nation's health-insurance coverage of essential drugs has expanded to include a much larger portion of the population based on average urban income level. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts